Dr Andrew Sim, MD - Medicare Pain Management in Fair Lawn, NJ

Dr Andrew Sim, MD is a medicare enrolled "Anesthesiology - Pain Medicine" physician in Fair Lawn, New Jersey. He graduated from medical school in 2011 and has 13 years of diverse experience with area of expertise as Pain Management. He is a member of the group practice All Be Healthy Llc and his current practice location is 2-22 Banta Pl, Fair Lawn, New Jersey. You can reach out to his office (for appointments etc.) via phone at (732) 784-3578.

Dr Andrew Sim is licensed to practice in New Jersey (license number 25MA09853100) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1912295122.

Contact Information

Dr Andrew Sim, MD
2-22 Banta Pl,
Fair Lawn, NJ 07410-3058
(732) 784-3578
(732) 924-3147



Physician's Profile

Full NameDr Andrew Sim
GenderMale
SpecialityPain Management
Experience13 Years
Location2-22 Banta Pl, Fair Lawn, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Andrew Sim graduated from medical school in 2011
  NPI Data:
  • NPI Number: 1912295122
  • Provider Enumeration Date: 07/21/2011
  • Last Update Date: 09/19/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3870889231
  • Enrollment ID: I20160912000122

Medical Identifiers

Medical identifiers for Dr Andrew Sim such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1912295122NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207LP2900XAnesthesiology - Pain Medicine 25MA09853100 (New Jersey)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
All Be Healthy Llc195179662239

News Archive

Extra radiation dose prevents breast cancer return in young women

Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation (boost dose) after undergoing breast-conserving surgery (lumpectomy) and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose, according to a large European study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

Euthymics's EB-1010 effective in treatment of major depressive disorder: Study

Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.

Mechanism provides beneficial characteristics of energy-burning brown fat to white fat

Columbia University Medical Center (CUMC) researchers have identified a mechanism that can give energy-storing white fat some of the beneficial characteristics of energy-burning brown fat. The findings, based on studies of mice and of human fat tissue, could lead to new strategies for treating obesity and type 2 diabetes.

Research released this week supports the House of Commons vote to make all workplaces smoke free

A team of researchers visited 64 pubs across the north west of England. They measured air quality using a portable monitor for at least 30 minutes in an area of the pub where smoking was allowed.

Avrio Biopharmaceuticals receives Cal FDB approval to manufacture and ship pharmaceutical products

Avrio Biopharmaceuticals, LLC, a wholly-owned subsidiary of Irvine Pharmaceutical Services, Inc., received approval to manufacture and ship pharmaceutical products by the California Department of Public Health, Food and Drug Branch (Cal FDB), completing the organization's portfolio of product development services in support of its pharmaceutical, biopharmaceutical, and medical device clients.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Andrew Sim allows following entities to bill medicare on his behalf.
Entity NameAll Be Healthy Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275286148
PECOS PAC ID: 1951796622
Enrollment ID: O20220316001364

News Archive

Extra radiation dose prevents breast cancer return in young women

Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation (boost dose) after undergoing breast-conserving surgery (lumpectomy) and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose, according to a large European study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

Euthymics's EB-1010 effective in treatment of major depressive disorder: Study

Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.

Mechanism provides beneficial characteristics of energy-burning brown fat to white fat

Columbia University Medical Center (CUMC) researchers have identified a mechanism that can give energy-storing white fat some of the beneficial characteristics of energy-burning brown fat. The findings, based on studies of mice and of human fat tissue, could lead to new strategies for treating obesity and type 2 diabetes.

Research released this week supports the House of Commons vote to make all workplaces smoke free

A team of researchers visited 64 pubs across the north west of England. They measured air quality using a portable monitor for at least 30 minutes in an area of the pub where smoking was allowed.

Avrio Biopharmaceuticals receives Cal FDB approval to manufacture and ship pharmaceutical products

Avrio Biopharmaceuticals, LLC, a wholly-owned subsidiary of Irvine Pharmaceutical Services, Inc., received approval to manufacture and ship pharmaceutical products by the California Department of Public Health, Food and Drug Branch (Cal FDB), completing the organization's portfolio of product development services in support of its pharmaceutical, biopharmaceutical, and medical device clients.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Andrew Sim is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Andrew Sim, MD
2-22 Banta Pl,
Fair Lawn, NJ 07410-3058

Ph: (732) 719-7168
Dr Andrew Sim, MD
2-22 Banta Pl,
Fair Lawn, NJ 07410-3058

Ph: (732) 784-3578

News Archive

Extra radiation dose prevents breast cancer return in young women

Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation (boost dose) after undergoing breast-conserving surgery (lumpectomy) and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose, according to a large European study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

Euthymics's EB-1010 effective in treatment of major depressive disorder: Study

Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.

Mechanism provides beneficial characteristics of energy-burning brown fat to white fat

Columbia University Medical Center (CUMC) researchers have identified a mechanism that can give energy-storing white fat some of the beneficial characteristics of energy-burning brown fat. The findings, based on studies of mice and of human fat tissue, could lead to new strategies for treating obesity and type 2 diabetes.

Research released this week supports the House of Commons vote to make all workplaces smoke free

A team of researchers visited 64 pubs across the north west of England. They measured air quality using a portable monitor for at least 30 minutes in an area of the pub where smoking was allowed.

Avrio Biopharmaceuticals receives Cal FDB approval to manufacture and ship pharmaceutical products

Avrio Biopharmaceuticals, LLC, a wholly-owned subsidiary of Irvine Pharmaceutical Services, Inc., received approval to manufacture and ship pharmaceutical products by the California Department of Public Health, Food and Drug Branch (Cal FDB), completing the organization's portfolio of product development services in support of its pharmaceutical, biopharmaceutical, and medical device clients.

Read more News

› Verified 5 days ago


Anesthesiology Doctors in Fair Lawn, NJ

Dr. Alexander Shorshtein, M.D.
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 41-26 Erli Rd, Fair Lawn, NJ 07410
Phone: 201-600-0292    
Dr. Vijay Gupta, M.D.
Anesthesiology
Medicare: May Accept Medicare Assignments
Practice Location: 28-06 Broadway, Fair Lawn, NJ 07410
Phone: 201-475-8940    
Joanne Naamo Owsiak, MD
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 31-00 Broadway, Fair Lawn, NJ 07410
Phone: 201-645-1010    Fax: 201-797-0044
Dr. Philip David Bamberger, M.D.
Anesthesiology
Medicare: Medicare Enrolled
Practice Location: 28-06 Broadway, Fair Lawn, NJ 07410
Phone: 201-475-8940    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.